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I-27 TARGETING NF-KAPPAB SIGNALING IN OA: IS IT ONLY
ABOUT INFLAMMATION?
K.B. Marcu1,2, E. Olivotto3, S. Pagani3, A. Facchini3, R. Borzi3. 1Stony
Brook University, Stony Brook, NY, USA, 2University of Bologna,
Bologna, ITALY, 3Rizzoli Institute, Bologna, ITALY
Purpose: To provide evidence in support of the hypothesis that selectively
impeding OA chondrocyte differentiation towards a hypertrophic-like state
(by blocking NF-kappaB independent functions of IKKalpha) could repre-
sent a rational strategy for ameliorating the course of OA disease. Without
argument OA is a complex often considered untreatable disease that
develops with ageing due to a variety of genetic and environmental phe-
nomena. Abnormal, progressive changes occur in the delicate balance
between anabolic and catabolic processes of chondrocyte homeostasis
in OA, thereby tipping the balance in favor of deregulated catabolic
activity, excessive ECM remodeling and thus cartilage degradation. This
excessive degree of cartilage destruction has a strong inﬂammatory
component, as is the case for other debilitating, ageing associated
diseases; but it remains unclear whether an inﬂammatory state actually
initiates or exacerbates OA phenotype. Importantly OA pathology is also
characterized by cycles of attempts at faulty ECM repair and enhanced
angiogenesis in conjunction with chondrocyte hypertrophy leading to
abnormal endochondral ossiﬁcation that produces underlying bone thick-
ening and the appearance of bony outgrowths. The latter features of OA
disease are suggestive of speciﬁc perturbations in cellular homeostasis
characterized by faulty, inappropriate chondrocyte differentiation. Along
this line of reasoning selectively impeding adult articular chondrocyte
differentiation towards a hypertrophic-like condition in OA could represent
a logical strategy for stabilizing chondrocyte ECM and maintaining their
normal homeostasis in general to avoid the onset of disease phenotype.
In this regard experimental evidence will be presented that IKKalpha
plays a surprisingly NF-kappaB independent, important role in modulating
the onset of ECM remodeling in conjunction with the conversion of
chondrocytes to a hypertrophic-like status and as such could represent
a novel OA target.
Methods: Stable retroviral transduction of targeted interfering RNAs
into OA and normal chondrocytes, in vitro chondrocyte differentiation,
immunohistochemistry, immunoblotting, Elisa, real time PCR.
Results: Ablation of either IKKbeta or IKKalpha expression blocked ECM
remodeling and chondrocyte differentiation by NF-kappaB dependent
and independent mechanisms respectively. Importantly IKKalpha knock-
down (KD) profoundly blocked chondrocyte differentiation prior to the
onset of ECM remodeling. Moreover IKKalpha compromised articular
chondrocytes maintained a highly organized ECM in conjunction with
enhanced cell viability. IKKalpha KD suppressed MMP13 activity but not
its expression. Interestingly we also ﬁnd that IKKalpha KD and MMP13
KD chondrocytes share a number of common features.
Conclusions: The NF-kappaB signaling pathway and a signiﬁcant por-
tion of its downstream target genes are well known to orchestrate cellular
stress-like responses. Moreover NF-kappaB deregulation strongly con-
tributes to the poor prognosis of diseases with a strong inﬂammatory
component, thus also making it a preferred OA target. However anti-NF-
kappaB based therapeutics can be a double edged sword due to poten-
tially deleterious consequences for cell survival and other targeted anti-
inﬂammatory modalities (including anti-MMP or anti-Cox or anti-Il-1beta
based therapeutics) can cause unwanted, collateral side affects. Our new
ﬁndings provide evidence that IKKalpha, in a kinase and NF-kappaB
independent pathway, could represent a novel OA disease target. Future
experiments will in part be devoted to establishing a functional role for
IKKalpha in an in vivo OA model, wherein IKKalpha ablation is induced in
murine chondrocytes in vivo during the course of experimentally induced
OA disease.
I-28 INFLAMMATION IN OA AS A TREATMENT TARGET
F. Iannone Sr, G. Lapadula Sr.. DiMIMP – Rheumatology Unit, Bari,
ITALY
Purpose: Osteoarthritis (OA) is a multifactorial disease in which joint
failure results from an intricate interplay among the pathologic processes
taking place in cartilage, synovial membrane (SM) and subchondral bone.
The speciﬁc contribute of each of these tissues in determining the joint
damage is matter of debate. SM is generally believed to play a minor role
in OA pathogenesis and to be involved following the release of cartilage
debris that would induce the SM reaction and inﬂammation. Inﬂamed
SM secrete an array of proinﬂammatory molecules which implement the
cartilage damage by promoting the activation of MMP (metalloproteinase)
cascade leading to matrix breakdown.
We focused on the possible early involvement of the SM in OA patho-
physiology and on the role of some inﬂammatory mediators in causing
cartilage damage.
Methods: We induced right knee OA in nine goats by resecting the ante-
rior cruciate ligament (ACL). Histology of SM, cartilage and subchondral
bone was performed and the expression of Il-1 and Il-4 was assessed by
immunohistochemistry and ﬂowcytometry. Our experimental model has
shown that cartilage and SM were ﬁrstly and simultaneously involved
in OA (at 1 month) whilst morphometric analysis of subchondral bone
detected signiﬁcant differences between OA and control knee only after
6 months. Furthermore, the expression of Il-1 was already increased
in SM at 1 month and, interestingly, the intracellular levels of Il-4 were
signiﬁcantly increased in OA cultured osteoblasts not before 3 months.
Results: Among the proinﬂammatory mediators produced by the SM,
substance P (SP) is an intriguing molecule with pleiotropic functions. SP
is a neuropeptide released from the ﬁbers C terminal nerve endings
and plays a pivotal role in controlling nociception, vascular tone and
inﬂammation. SP has been found increased in synovitis and is also
directly produced by synoviocytes. We demonstrated that chondrocytes
synthesize SP and its expression increased in human OA chondrocytes
both at mRNA (RT-PCR) and protein (ﬂocytometry) levels. Furthermore,
the cell-membrane bound peptidases (CD10 and CD26), which hydrolyze
the neuropeptides, were found decreased on OA human chondrocyte
surface. To further explore the role of SP in cartilage metabolism and OA
pathogenesis, we studied its effect on proteoglycans (PG) remodeling and
aggrecanase-5 (ADAMTS-5) and MMP-13 synthesis. Preliminary data
suggest the SP (10−8 M) increases the breakdown of PG from both OA
and normal cartilage explants, as indicated by reduced safranin staining,
and enhances the release of ADAMTS-5 and MMP-13 (western blot).
Preincubation with spantide II (a selective antagonist of SP) prevents
these effects. Nevertheless, TIMP-3, a speciﬁc inhibitor of ADAMTS-5,
does not seem to be regulated by SP. Hence, SP, beside its proinﬂam-
matory functions, exerts a direct effect on matrix cartilage remodeling
and its increase in OA may represent a further mechanism of cartilage
damage.
Conclusions: The relevance of inﬂammation in OA pathophysiology is
worthy of further studies since its role in OA is not limited to appearance
of pain but directly takes part to joint damage and its targeting, since
the early stage of disease, with selective modulators can be a promising
strategy to cure OA.
I-29 DISCOVERY AND VALIDATION OF AN IMMUNOAFFINITY
LC-MS/MS ASSAY FOR THE QUANTIFICATION OF THE
COLLAGEN TYPE II NEOEPITOPE PEPTIDE BIOMARKER
O. Nemirovskiy1, W. Li2, S. Fountain2, T. Sunyer1, W. Mathews1,
G. Szekely-Klepser3, M-P. Hellio Le Graverand4. 1Pﬁzer, Inc., St. Louis,
MO, USA, 2Pﬁzer, Inc., La Jolla, CA, USA, 3Assay Designs, Ann Arbor,
MI, USA, 4Pﬁzer, Inc., Groton, CT, USA
Purpose: To validate an assay for the quantiﬁcation of type II collagen
neoepitope (TIINE) peptides for its biomarker applications. Application of
a biomarker in scientiﬁc decision making requires its validation for the
given purpose and therefore, should include two distinct activities: tech-
nical validation of the assay procedure and biological/pharmacological
validation for its ﬁt-for-purpose use. This work describes recent discovery
and analytical validation of the immunoafﬁnity LC-MS/MS assay for the
quantiﬁcation of the TIINE 45-mer peptide in human urine to demonstrate
that the assay is speciﬁc, sensitive and reliable (precise and accurate) for
measuring type II collagen breakdown in clinical settings.
Methods: Quantitation of TIINE-containing 45-mer peptides with
5-hydroxyproline (HyP) was performed by two-dimensional LC-MS/MS,
utilizing an HP1100 high-performance liquid chromatography (HPLC)
system, a CTC Analytics HTS PAL autosampler, switching valve, and
interfaced to an API 4000 triple quadrupole mass spectrometer. A 45-
mer peptide containing 5-Hyp that was deuterated (d5) at the C-terminal
glutamine residue was used as an internal standard. The standard curve
of the 45-mer TIINE peptide was prepared in aqueous solution with
protein present (10 mg/mL of BSA), whereas quality control samples
were made in urine matrix. Methods used for validation were based on
utilizing the authentic peptide spiked into urine samples and evaluated
for sensitivity, selectivity, linearity, accuracy and precision as well as
carry-over, long and short-term stability. Urine samples from the second
morning void were collected without preservatives, aliquoted for separate
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analysis for creatinine and the TIINE peptide and stored at −70ºC until
analysis.
Results: Method performance and validation characteristics were estab-
lished for the immunoafﬁnity LC-MS/MS assay aimed at measuring the
45-mer with 5HyP in human urine. Validation experiments were designed
to address speciﬁc challenges related to quantiﬁcation of endogenous
analytes. The validated method has been shown to be sensitive (lower
limit of quantiﬁcation (LLOQ) 0.156 ng/mL), selective, accurate (<15%
RE), and precise (<15% CV) over a linear range of 0.156−7.5 ng/mL. The
recovery of the 45-mer peptide from the urine samples of 6 subjects was
ranging from 94.2%-108%, which indicated that the recovery was urine
matrix independent. Accuracy and precision of spiked dilution linearity
samples at 2, 4, 10, and 20-fold dilutions were <15% RE and <15%
CV, respectively. Sample stability and inter- and intra-subject variability
have been evaluated in the urine of normal and OA populations. The
method has been applied to analyze human urine samples from clinical
studies. Urinary TIINE 45-mer was consistently found to be elevated in
symptomatic patients with X-ray OA in the knee or hip (135±9 ng/mM
creatinine) as compared to levels in non-OA subjects (65±12 ng/mM),
indicating increase type II breakdown. Moreover, urinary TIINE 45-mer
was found to be inhibited in healthy volunteers upon administration of
MMP inhibitors in a dose- and time-dependent manner.
Conclusions: The immunoafﬁnity LC-MS/MS assay to quantify the most
abundant urinary type II collagen neoepitope peptide provides highly
accurate and precise concentration determination with minimal sample
preparation and has been successfully employed in clinical studies aimed
at validating the 45-mer TIINE peptide as a biomarker for MMP activity
and its role in osteoarthritis.
I-30 MICROARRAY GENE EXPRESSION PROFILING OF HUMAN
OSTEOARTHRITIC BONE SUGGESTS ALTERED BONE
REMODELLING, WNT AND TGF BETA/BMP SIGNALING
D.M. Findlay1,2, B. Hopwood3, A. Tyskin1, N.L. Fazzalari3,2. 1University
of Adelaide, Adelaide, AUSTRALIA, 2Hanson Institute, Adelaide,
AUSTRALIA, 3Institute of Medical and Veterinary Science, Adelaide,
AUSTRALIA
Purpose: In addition to degenerative changes in the articular cartilage,
osteoarthritis (OA) is characterised by alterations to subchondral bone.
Changes to bone in OA, which include increased bone volume fraction
and reduced bone mineralisation, have also been identiﬁed at sites distal
to the affected joint. Altered bone remodelling has been proposed to
underlie these bone changes in OA. To investigate the molecular basis
for these changes, we performed gene expression analysis in bone from
the proximal femur of OA and control individuals.
Methods: Messenger RNA prepared from cancellous bone samples, ob-
tained from the proximal femur, were used for both targeted gene analysis,
investigating genes thought to be centrally involved in bone turnover, and
gene microarray, using Compugen human 19K-oligo microarray slides.
In the latter experiments, we compared the gene expression proﬁles of
four sets of OA, CTL and OP bone samples (40 comparisons in total),
comprising 10 OA – CTL female, 10 OA – CTL male, 10 OA – OP female
and 10 OP – CTL female sample pairs.
Results: We identiﬁed clear expression differences between genes such
as osteocalcin, osteopontin and type I collagen, between control and
OA bone. In the microarray experiments, a large number of differentially
expressed genes was identiﬁed, and twenty-ﬁve of these genes were
conﬁrmed to be differentially expressed (p < 0.01) by real time PCR
analysis. A substantial number of the top-ranking differentially expressed
genes identiﬁed in OA bone are known to have roles in osteoblasts,
osteocytes and osteoclasts. Many of these genes are targets of either the
WNT or TGFb/BMP signalling pathways. Other differentially expressed
genes included WNT or TGFb/BMP identiﬁed as differentially expressed
in OA bone between females and males, consistent with our other data
showing biochemical differences between males and females with OA.
Conclusions: The limitation of this work is that samples were taken
at end stage disease. However, altered expression of sets of genes
involved in bone turnover suggests a molecular basis for the altered bone
remodelling observed throughout OA progression. These data may also
in part explain the gender disparity observed in OA.
I-31 PATTERNS OF JOINT DISTRIBUTION IN HAND
OSTEOARTHRITIS: GENETIC CONSIDERATIONS
G. Livshits. Tel Aviv University, Tel Aviv, ISRAEL
Purpose: 1. To examine the pattern of joint distribution in radiographic
hand osteoarthritis (HOA) development in apparently healthy human
population and to assess contribution of sex and age on it. 2. To test
the effect of the various joint degeneration features to Kellgren-Lawrence
(K-L) score of the different joints and in total. 3. To evaluate contribution
of the putative genetic factors to inter-individual variation of HOA. 4. To
test the association of the extracellular pyrophosphate channel genes
(speciﬁcally ENPP1) with the variation of the radiographic HOA in the
above population.
Methods: The study sample was comprised of Chuvashains (Europeans
living along Volga river in Russia): 1,200 individuals of both sexes, with
age range between 19 and 90 years. HAO development was assessed
radiographically for 15 joints of each hand according to K-L grading
system, with modiﬁcations. First, using extensive statistical analysis we
examined the rate and pattern of age related changes of each type
of joints (DIP, PIP etc) and each ﬁnger separately in both sexes. We
also assessed quantitatively the relative contribution of the speciﬁc joint
degeneration characteristics (such as osteophytes, OS; joint space nar-
rowing JSN; subchondral cysts, SC; etc) to the K-L grade for each type
of joint and in total. Next, 12 DNA polymorphisms, located within and
in vicinity of ENPP1 were tested in 126 nuclear families with 574 adult
individuals. Family-based association analysis was conducted between
these markers and total K-L score of HOA.
Results: As expected, we found very strong association of HAO with
age, with only minor differences between the sexes. However, the rate of
the K-L scores appearance varied substantially between the ﬁngers and
especially between the joints. The ﬁfth ﬁnger and DIP joints showed the
highest vs the ﬁrst ﬁnger and IP1 joint the lowest rate of degeneration
respectively. Cluster analysis for rows of joints and joint groups of both
hands revealed that symmetry is the most common pattern of interrela-
tionships between rows of joints as well as between the ﬁngers, when the
later were compared as entire units. The contribution of the different joint
degeneration characteristics to K-L score was very different: OS made the
major contribution to all types of joints and in total, ranging from 50% to
80%. SC was the second predictor, contributing between 10% to 23% to
K-L score. The rest made only minor contribution. Model-based statistical
genetic analysis of the total K-L score, adjusted for age and sex, showed
highly signiﬁcant contribution of the familial factors explaining >25% of
the trait variation. The model ﬁtting analysis also strongly supported the
hypothesis of the genetic effect on the OS score variation alone. Testing
for the association with DNA polymorphisms in ENPP1 gene consistently
showed signiﬁcant association (p< 0.05–0.001) with this gene, suggesting
its involvement in HOA development.
Conclusions: The present data show that the rate of HOA development
associated with age varied signiﬁcantly between the different types of
joints and ﬁngers, with osteophytosis as a major predictor of OA at all
joints. Our study highlights signiﬁcant genetic contribution to interindivid-
ual variability of HOA and clearly suggest ENPP1 gene as an important
genetic factor in the pathogenesis of idiopathic osteoarthritis.
I-32 PHENOTYPING EROSIVE OSTEOARTHRITIS OF THE HAND
L. Punzi, R. Ramonda. Rheumatology Unit-University of Padova,
Padova, ITALY
Purpose: Erosive osteoarthritis of the hand (EOA) is characterised by
an aggressive clinical course and the presence of erosive radiographic
changes. Over time, EOA has been considered as a variant of OA, a
subset of OA, a severe form of OA, an inﬂammatory phase of OA, and
an entity distinct from OA. Our aim is to phenotype EOA in order to
demonstrate that it is a distinctive subset of hand OA.
Methods:We examined studies analysing characteristic features of EOA,
including clinical, radiographic and laboratory aspects. The diagnosis
of EOA was usually based on ACR clinical criteria for hand OA and
radiographic aspects of articular erosions, at least two in two different IPs
and with the exclusion of MCPs. The deﬁnition of erosion is still a matter
for debate. Most frequently, lesions begin at the central portion of the
joint as a sharply marginated defect, usually preceded by joint narrowing.
Progression commonly leads to the so-called ‘gull-wing’ deformity due
to marginal sclerosis and osteophytes of the distal side of the joints,
while the proximal side is centrally eroded or collapsed and thinned.
Subchondral pseudocysts may be observed on the proximal side. Another
